BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4007280)

  • 1. Production in yeast of hepatitis B surface antigen by R-DNA technology.
    De Wilde M; Cabezon T; Harford N; Rutgers T; Simoen E; Van Wijnendaele F
    Dev Biol Stand; 1985; 59():99-107. PubMed ID: 4007280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties and relative immunogenicity of various preparations of recombinant DNA-derived hepatitis B surface antigen.
    Burnette WN; Samal B; Browne J; Ritter GA
    Dev Biol Stand; 1985; 59():113-20. PubMed ID: 3159608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of hepatitis B surface antigen in yeast.
    Harford N; Cabezon T; Crabeel M; Simoen E; Rutgers A; De Wilde M
    Dev Biol Stand; 1983; 54():125-30. PubMed ID: 6653884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
    Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
    Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and expression of the preS1 gene of hepatitis B virus in yeast cells.
    Lu YY; Li K; Cheng J; Wang L; Liu Y; Zhang LX
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):238-42. PubMed ID: 14612275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of hepatitis B surface antigen in mammalian cells and identification of a precursor form of HBsAg.
    Siddiqui A
    Dev Biol Stand; 1983; 54():119-23. PubMed ID: 6418589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen.
    Desombere I; Willems A; Gijbels Y; Leroux-Roels G
    J Virol; 2006 Apr; 80(7):3506-14. PubMed ID: 16537618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, purification, and characterization of hepatitis B virus surface antigens (HBsAg) in yeast Pichia Pastoris.
    Liu R; Lin Q; Sun Y; Lu X; Qiu Y; Li Y; Guo X
    Appl Biochem Biotechnol; 2009 Aug; 158(2):432-44. PubMed ID: 19184543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and expression of the hepatitis B virus genome.
    Wain-Hobson S; Pourcel C; Brechot C; Charnay P; Dubois MF; Fritsch A; Gervais M; Louise A; Tiollais P
    Dev Biol Stand; 1981; 50():293-300. PubMed ID: 6281110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B vaccines prepared from yeast by recombinant DNA techniques: memorandum from a WHO meeting.
    Bull World Health Organ; 1985; 63(1):57-61. PubMed ID: 3886186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of hepatitis B surface antigen produced in yeast.
    Choo KB; Wu SM; Lee HH; Lo SC
    Biochem Biophys Res Commun; 1985 Aug; 131(1):160-6. PubMed ID: 3899110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenicity and immunogenicity of the immunodominant region of hepatitis B surface antigen displayed on bacteriophage T7.
    Tan GH; Yusoff K; Seow HF; Tan WS
    J Med Virol; 2005 Dec; 77(4):475-80. PubMed ID: 16254965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 49,000-dalton polypeptide bearing all antigenic determinants and full immunogenicity of 22-nm hepatitis B surface antigen particles.
    Mishiro S; Imai M; Takahashi K; Machida A; Gotanda T; Miyakawa Y; Mayumi M
    J Immunol; 1980 Apr; 124(4):1589-93. PubMed ID: 6154075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assembly of hepatitis delta virus-like empty particles in yeast.
    Wu HL; Chen PJ; Mu JJ; Chi WK; Kao TL; Hwang LH; Chen DS
    Virology; 1997 Sep; 236(2):374-81. PubMed ID: 9325245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B surface antigen polypeptide micelles from antigen expressed in Saccharomyces cerevisiae.
    Howard CR; Young PR; Lee S; Dixon J; Zuckerman AJ; McAleer WJ; Lehman ED
    J Virol Methods; 1986 Aug; 14(1):25-35. PubMed ID: 2945830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable HBV surface antigen expression by Vero cell clones after transfection.
    Colbére-Garapin F; Horaud F; Kourilsky P; Garapin AC
    Dev Biol Stand; 1985; 59():109-12. PubMed ID: 4007271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antigenic properties of mutant hepatitis B virus surface antigen].
    Guo MZ; Yi Y; Chen SY; Bai Y; Jia ZY; Bi SL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Feb; 22(1):48-50. PubMed ID: 18414700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of surface promoter mutations in hepatitis B surface antigen production and secretion in occult hepatitis B virus infection.
    Sengupta S; Rehman S; Durgapal H; Acharya SK; Panda SK
    J Med Virol; 2007 Mar; 79(3):220-8. PubMed ID: 17245717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.